𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Inhibition of proliferation and induction of apoptosis by EGCG in human osteogenic sarcoma (HOS) cells

✍ Scribed by Sang Jin Ji; Dong Hoon Han; Jeong Hee Kim


Publisher
Springer
Year
2006
Tongue
English
Weight
689 KB
Volume
29
Category
Article
ISSN
0253-6269

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Inhibition of cell proliferation and ind
✍ Eddi Di Marco; Nadia Sessarego; Barbara Zerega; Ranieri Cancedda; Fiorella Desca πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 363 KB

## Abstract Ex‐FABP, an extracellular fatty acid binding lipocalin, is physiologically expressed by differentiating chicken chondrocytes and myoblasts. Its expression is enhanced after cell treatment with inflammatory stimuli and repressed by anti‐inflammatory agents, behaving as an acute phase pro

Inhibition of proliferation and inductio
✍ Nobuhiko Oridate; Dafna Lotan; Michele Follen Mitchell; Waun K. Hong; Reben Lota πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 647 KB

The effects of retinoids including all-trans-retinoic acid (ATRA), 13-CIS-RETINOIC ACID (13CRA), and N-(4-hydroxyphenyl)retinamide (4-HPR) on several cervical carcinoma cell lines in culture were investigated as a prelude to investigating the mechanisms underlying the chemopreventive potential of re

Regulation of signaling pathways involve
✍ Sahdeo Prasad; Nidhi Nigam; Neetu Kalra; Yogeshwer Shukla πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 318 KB

The above article, published online on April 10 2008 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor in Chief and Wiley Periodicals, Ltd. The retraction has been agreed due to data duplication, both from previous papers from the same group

Inhibition of survivin reduces cell prol
✍ Zhihong Ai; Lianhua Yin; Xianrong Zhou; Ying Zhu; Dongmei Zhu; Yinhua Yu; Youji πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 765 KB

## Abstract ## BACKGROUND Endometrial cancer is a common gynecologic malignancy among women. The molecular mechanisms involved in the progression of endometrial cancer are unclear, which has hampered the development of an effective treatment. Survivin, a newly identified member of the inhibitor of